
Michael C. Wilson
Examiner (ID: 16269, Phone: (571)272-0738 , Office: P/1632 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1638, 1633, 1632 |
| Total Applications | 1637 |
| Issued Applications | 556 |
| Pending Applications | 303 |
| Abandoned Applications | 820 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19281851
[patent_doc_number] => 20240218325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-04
[patent_title] => MULTIPOTENT ADULT STEM CELLS: CHARACTERIZATION AND USE
[patent_app_type] => utility
[patent_app_number] => 18/450896
[patent_app_country] => US
[patent_app_date] => 2023-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13532
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18450896
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/450896 | MULTIPOTENT ADULT STEM CELLS: CHARACTERIZATION AND USE | Aug 15, 2023 | Abandoned |
Array
(
[id] => 18806062
[patent_doc_number] => 20230380391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => TRAIT SELECTION IN AVIANS
[patent_app_type] => utility
[patent_app_number] => 18/339917
[patent_app_country] => US
[patent_app_date] => 2023-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25777
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18339917
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/339917 | TRAIT SELECTION IN AVIANS | Jun 21, 2023 | Abandoned |
Array
(
[id] => 18860240
[patent_doc_number] => 20230414674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => METHODS AND COMPOSITIONS FOR HAIR FOLLICLE GENERATION
[patent_app_type] => utility
[patent_app_number] => 18/325745
[patent_app_country] => US
[patent_app_date] => 2023-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15354
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18325745
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/325745 | METHODS AND COMPOSITIONS FOR HAIR FOLLICLE GENERATION | May 29, 2023 | Pending |
Array
(
[id] => 18806893
[patent_doc_number] => 20230381226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => SURFACE-ENGINEERED EXTRACELLULAR VESICLES AND THERAPEUTIC USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/322723
[patent_app_country] => US
[patent_app_date] => 2023-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15019
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18322723
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/322723 | SURFACE-ENGINEERED EXTRACELLULAR VESICLES AND THERAPEUTIC USES THEREOF | May 23, 2023 | Pending |
Array
(
[id] => 18859357
[patent_doc_number] => 20230413790
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => GENETICALLY EDITED ALBINO-RED GERMLINES OF TILAPIA FISH
[patent_app_type] => utility
[patent_app_number] => 18/197151
[patent_app_country] => US
[patent_app_date] => 2023-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18863
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18197151
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/197151 | GENETICALLY EDITED ALBINO-RED GERMLINES OF TILAPIA FISH | May 14, 2023 | Pending |
Array
(
[id] => 19430121
[patent_doc_number] => 20240298619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => NON-HUMAN ANIMALS HAVING A HUMANIZED PROGRAMMED CELL DEATH 1 GENE
[patent_app_type] => utility
[patent_app_number] => 18/316461
[patent_app_country] => US
[patent_app_date] => 2023-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26890
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18316461
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/316461 | NON-HUMAN ANIMALS HAVING A HUMANIZED PROGRAMMED CELL DEATH 1 GENE | May 11, 2023 | Pending |
Array
(
[id] => 18770838
[patent_doc_number] => 20230365638
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-16
[patent_title] => ETV2 AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/309466
[patent_app_country] => US
[patent_app_date] => 2023-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8152
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18309466
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/309466 | ETV2 AND USES THEREOF | Apr 27, 2023 | Abandoned |
Array
(
[id] => 19525804
[patent_doc_number] => 20240349706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-24
[patent_title] => Novel Animal Model for Autoimmune Disease
[patent_app_type] => utility
[patent_app_number] => 18/305342
[patent_app_country] => US
[patent_app_date] => 2023-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5696
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18305342
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/305342 | Novel Animal Model for Autoimmune Disease | Apr 21, 2023 | Pending |
Array
(
[id] => 19262743
[patent_doc_number] => 20240206438
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => SIMPLE AND RAPID CONSTRUCTION OF RAT MODEL OF CONSTIPATION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/301271
[patent_app_country] => US
[patent_app_date] => 2023-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5992
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18301271
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/301271 | SIMPLE AND RAPID CONSTRUCTION OF RAT MODEL OF CONSTIPATION AND USE THEREOF | Apr 16, 2023 | Pending |
Array
(
[id] => 18737939
[patent_doc_number] => 20230346841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => COMPOSITIONS, METHODS AND USES FOR IN VITRO AND IN VIVO GENERATION OF FUNCTIONAL THYMIC TISSUE
[patent_app_type] => utility
[patent_app_number] => 18/132164
[patent_app_country] => US
[patent_app_date] => 2023-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13525
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18132164
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/132164 | COMPOSITIONS, METHODS AND USES FOR IN VITRO AND IN VIVO GENERATION OF FUNCTIONAL THYMIC TISSUE | Apr 6, 2023 | Pending |
Array
(
[id] => 18806911
[patent_doc_number] => 20230381244
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => Methods and Systems for Improved Therapies Using Photo-Activated Stem Cells
[patent_app_type] => utility
[patent_app_number] => 18/295661
[patent_app_country] => US
[patent_app_date] => 2023-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17489
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 156
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18295661
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/295661 | Methods and Systems for Improved Therapies Using Photo-Activated Stem Cells | Apr 3, 2023 | Pending |
Array
(
[id] => 18597600
[patent_doc_number] => 20230272397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => METHODS FOR IMPROVING THE HEALTH OF PORCINE SPECIES BY TARGETED INACTIVATION OF CD163
[patent_app_type] => utility
[patent_app_number] => 18/192492
[patent_app_country] => US
[patent_app_date] => 2023-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45082
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18192492
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/192492 | Methods for improving the health of porcine species by targeted inactivation of CD163 | Mar 28, 2023 | Issued |
Array
(
[id] => 18739941
[patent_doc_number] => 20230348910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => COMPOSITIONS AND METHODS FOR GENETIC MODIFICATION AND TARGETING
[patent_app_type] => utility
[patent_app_number] => 18/188315
[patent_app_country] => US
[patent_app_date] => 2023-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36941
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18188315
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/188315 | COMPOSITIONS AND METHODS FOR GENETIC MODIFICATION AND TARGETING | Mar 21, 2023 | Pending |
Array
(
[id] => 18451590
[patent_doc_number] => 20230192868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-22
[patent_title] => ANTI-IGF-I RECEPTOR ANTIBODY
[patent_app_type] => utility
[patent_app_number] => 18/177718
[patent_app_country] => US
[patent_app_date] => 2023-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26723
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18177718
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/177718 | ANTI-IGF-I RECEPTOR ANTIBODY | Mar 1, 2023 | Abandoned |
Array
(
[id] => 18522149
[patent_doc_number] => 20230232797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => NON-HUMAN ANIMALS COMPRISING A HUMANIZED ALBUMIN LOCUS
[patent_app_type] => utility
[patent_app_number] => 18/175010
[patent_app_country] => US
[patent_app_date] => 2023-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46111
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18175010
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/175010 | Method of using a genetically modified mouse that expresses human albumin | Feb 26, 2023 | Issued |
Array
(
[id] => 19110413
[patent_doc_number] => 20240122163
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => A METHOD FOR CONSTRUCTING A COFILIN-1 TRANSGENIC MODEL AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/165038
[patent_app_country] => US
[patent_app_date] => 2023-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3397
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18165038
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/165038 | A METHOD FOR CONSTRUCTING A COFILIN-1 TRANSGENIC MODEL AND USE THEREOF | Feb 5, 2023 | Pending |
Array
(
[id] => 18522998
[patent_doc_number] => 20230233651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => MATERIALS AND METHODS FOR TREATMENT OF TITIN-BASED MYOPATHIES AND OTHER TITINOPATHIES
[patent_app_type] => utility
[patent_app_number] => 18/162850
[patent_app_country] => US
[patent_app_date] => 2023-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28090
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18162850
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/162850 | Guide RNA for repairing a mutant human titin gene using CRISPR technology | Jan 31, 2023 | Issued |
Array
(
[id] => 18417716
[patent_doc_number] => 20230172172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => MOUSE MODEL OF DITRA DISEASE AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/159414
[patent_app_country] => US
[patent_app_date] => 2023-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18072
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159414
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/159414 | Mouse model of DITRA disease and uses thereof | Jan 24, 2023 | Issued |
Array
(
[id] => 18595299
[patent_doc_number] => 20230270087
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => Method for Constructing Ptgds Gene Knockout Rat Model with Spontaneous Kidney Yin Deficiency
[patent_app_type] => utility
[patent_app_number] => 18/155865
[patent_app_country] => US
[patent_app_date] => 2023-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6838
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18155865
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/155865 | Method for Constructing Ptgds Gene Knockout Rat Model with Spontaneous Kidney Yin Deficiency | Jan 17, 2023 | Pending |
Array
(
[id] => 18612627
[patent_doc_number] => 20230279359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => WNT PATHWAY STIMULATION IN REPROGRAMMING SOMATIC CELLS WITH NUCLEAR REPROGRAMMING FACTORS
[patent_app_type] => utility
[patent_app_number] => 18/091888
[patent_app_country] => US
[patent_app_date] => 2022-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30401
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18091888
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/091888 | WNT PATHWAY STIMULATION IN REPROGRAMMING SOMATIC CELLS WITH NUCLEAR REPROGRAMMING FACTORS | Dec 29, 2022 | Pending |